Search

everythinglearnresearchcommunity

for

Search:↓

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Type I interferons play a key role in the development of various skin diseases.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Use 5% minoxidil or oral finasteride for mild-to-moderate hair loss, combine with hair transplant for severe cases.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Ginsenoside Rb1 from Panax ginseng helps mink hair grow by activating certain cell signals.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

New compounds may soon be tested to treat excessive hair growth in women.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

The antiandrogen 11α-hydroxyprogesterone effectively reduces skin oil and cholesterol when applied to the skin.

Tannic acid helps wounds heal faster in rats by activating certain cell signals and reducing inflammation.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.